Price History

Hover for the daily close. The dotted line marks the period open.

Compare SDGR with… →

SDGR Key Statistics

As of Sep 4, 2026

Trading

Open: $20.58
Previous Close: $20.71
Day's Range: 19.69–20.67
52-Week Range: 10.95–23.02
Volume: 876.80K
Beta: 1.69

Valuation

Market Cap: $1.50B
P/E Ratio: unprofitable
P/S ratio: 5.80
EPS (ttm): −0.71

Financials (FY)

Revenue (FY): $255.87M+23.29%
Net Income (FY): −$103.27M
Profit margin: −20.98%
Shares Outstanding: 65.64M
1-Year Return: +5.90%

Dividend and dates

Earnings Date: November 4, 2026estimated
Avg Volume: 1.17M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SDGR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+176.47%−56.01%−46.34%+91.55%−46.12%−7.31%+12.36%

2020*202120222023202420252026*

Year	Return
2026 (partial year)	+12.36%
2025	−7.31%
2024	−46.12%
2023	+91.55%
2022	−46.34%
2021	−56.01%
2020 (partial year)	+176.47%

As of September 4, 2026.

SDGR Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$255.87M	−$103.27M	−40.4%
2024	$207.54M	−$187.12M	−90.2%
2023	$216.67M	$40.72M	18.8%
2022	$180.96M	−$149.19M	−82.4%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$255.87M	$142.61M	−$166.90M	−$103.27M	−40.4%
2024	$207.54M	$132.08M	−$209.30M	−$187.12M	−90.2%
2023	$216.67M	$140.69M	−$177.45M	$40.72M	18.8%
2022	$180.96M	$101.02M	−$146.82M	−$149.19M	−82.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SDGR Valuation vs Health Information Services Median

Median of 53 stocks

Metric	SDGR	Health Information Services median	vs median
P/S ratio	5.80	2.66	118% above
Profit margin	−20.98%	0.00%	21.0 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Schrödinger, Inc. (SDGR) is capitalised at $1.50B on the latest close. The company sits in the Healthcare sector, in the Health Information Services industry. Headcount on file is 850.

The 52-week range on file runs from $10.95 to $23.02. The most recent close on file for SDGR is $20.09, dated September 4, 2026. That is −$0.62 (−2.99%) against the previous close. The latest close sits 83.55% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $255.87M. Against the prior fiscal year total of $207.54M, that is a change of +23.29%. The same year closed with a net loss of $103.27M. The reported profit margin is −20.98%. That is 21 percentage points below the Health Information Services median of 0%. Earnings per share on a trailing basis come to −0.71.

Across the 4 fiscal years on file, revenue moves from $180.96M in 2022 to $255.87M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 5.8. On price-to-sales that is 118.2% above the Health Information Services median of 2.66. 53 Health Information Services companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned +5.90%. Measured over 5 years, that is −20.99% a year compounded. The reported beta is 1.69. Daily returns over the trailing 6 years annualize to a volatility of 64.1%.

Growth & Income

The record shows no dividend for SDGR.

2026 is still running; the price is +12.36% year to date. The strongest complete calendar year on file is 2023 at +91.55%; the weakest is 2021 at −56.01%. Of the 5 complete calendar years on file, 1 finished higher.

Peer Comparison

Schrödinger, Inc. (SDGR) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Schrödinger, Inc.	SDGR	$1.50B	—
Veeva Systems Inc.	VEEV	$44.54B	45.0
BrightSpring Health Services, Inc.	BTSG	$12.02B	54.7
Tempus AI, Inc.	TEM	$11.66B	—

The Health Information Services industry average P/E ratio is 41.1x. Schrödinger, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

BTSG

BrightSpring Health Services, Inc.

$12.02B

TEM

Tempus AI, Inc.

$11.66B

HQY

HealthEquity, Inc.

$7.95B

HNGE

Hinge Health, Inc.

$7.45B

WAY

Waystar Holding Corp.

$4.81B

View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Visit website →

Schrödinger, Inc. (SDGR) Stock Analysis